Cell and gene therapy tools
Integrating novel technologies in products for the cell and gene therapy market.
We accelerate the development and commercialisation of cutting-edge technology for systems and consumables tailored to the needs of therapy companies. We empower developers of cell and gene therapy solutions who seek to enhance industry operations, improve product quality, or scale manufacturing. With long-standing expertise in implementing novel technologies in product development and navigating the regulatory landscape, we provide the essential support needed to ensure a smooth path to market.
Accelerated development of cell and gene therapy solutions
The cell and gene therapy (CGT) market is rapidly growing and evolving, with the number of trials, modalities, and manufacturing processes consistently on the rise. As trends shift quickly, often driven by recent approvals, companies developing products for this market must be ready to adapt.
Creating solutions for the needs of CGT developers, including cell isolation, cell expansion systems, and genetic modification, poses significant challenges. As a product development company, you may identify valuable unmet needs, but tight timelines and the complexity of development can often exceed internal capability to execute.
When looking for an external partner for product development and design, it's essential to ensure they understand GMP-compliant equipment design and have proven success in creating systems suitable for highly regulated environments.
At TTP, we partner with companies that are pushing the boundaries of process automation to enable the progress of advanced therapies. Our team is uniquely positioned to address challenges at the intersection of biological systems and mechanical automation, where the combined expertise of biologists, chemists, physicists, and engineers is essential.
When you partner with us, we integrate into your product development process, bringing our deep understanding of manufacturing methods, customer expectations and regulatory requirements. Our proactive and flexible approach ensures your team can move forward confidently while we adapt to your evolving commercial objectives.
TTP’s development process is geared towards providing tangible outputs that add value to your product development strategy at each stage of the roadmap. Our multidisciplinary teams provide valuable insights, with their combined expertise ensuring a cohesive approach to product and technology development.
We are passionate about project delivery and committed to achieving a successful outcome. By partnering with TTP, you gain access to a team that accelerates the delivery of GMP-deployable products.
TTP has deep experience in life science instrumentation. Our vision for Cellular Highways drew on TTP’s capabilities in realising complex products, involving integrated mechanical, electrical, optical and fluidic systems.
Salman Samson Rogers
Co-Founder and CTO at Cellular Highways Ltd
Non-contact cell counting enables in-line, real-time monitoring of manufacturing processes
Cell counting is performed at numerous points during cell therapy manufacturing, and is normally performed on stand-alone devices requiring several manual preparation steps. Hence non-contact cell counting methods that can be implemented in-line are a key innovation to free up operator time and reduce measurement variability.
We spoke to TTP Project Leader, James Stein, on work he’s been doing to implement imaging as an in-line cell counting method. Read the interview here.
Personalised mRNA therapies are coming and will challenge established analytical technologies: Should we look to the diagnostics sector for improved Quality Control?
As personalised cancer vaccines gain momentum, scaling up their manufacturing has become a critical focus. This article explores the current challenges in ensuring scalability—from rigorous quality control to automation innovations—highlighting what it will take to make these breakthrough therapies widely accessible. Learn how advancements in process design and manufacturing technology are poised to bring personalised treatments to more patients without compromising quality.
For an in-depth look at the future of scalable cancer vaccine production, read the full article.
Invent: Life Science Podcast
Now back for its third season, TTP’s Invent: Life Science podcast uncovers the scientific and commercial insights behind cutting-edge developments within the Life Sciences industry. This season we’re throwing the spotlight on the remarkable potential of the cell and gene therapy industry.
With approvals for advanced therapies on the rise and ambitions to reach larger patient populations, it's the perfect time to take stock of the progress we've made so far and ask ‘what’s next?’. In our latest series, we'll discover the people, processes, and partnerships needed to build the future of this industry and deliver the best outcomes for the greatest number of patients.
How we can help
Strategy and planning
Navigating change, identifying business opportunities, balancing risk, timeline and cost from opportunity to launch.
Technology development
First-principles research, inventing enabling solutions and protecting Intellectual Property.
Software integration
GAMP 5 compliant software that connects your solution to MES/EBR systems.
Analytics, measurement and QC solutions
Combining expertise in sensing, molecular and cell biology, microfluidics, electronics, optics and AI.
Automation and instrumentation development
Flexible, highly-skilled and bespoke multi-disciplinary teams developing your solution, including biology to hardware integration, biology development and optimisation.
Prototyping and early stage manufacture
Manufacture of up to 100s of instruments and 1000s of cartridges.
Regulated development
Design of 13485 or GAMP 5 compliant systems, suitable for GMP manufacture.
Usability
Human factors assessment, design for usability, use error analysis.
Late stage troubleshooting
Rapid and scientific approach enables an informed, risk-based response.
Strategy and planning
Navigating change, identifying business opportunities, balancing risk, timeline and cost from opportunity to launch.
Technology development
First-principles research, inventing enabling solutions and protecting Intellectual Property.
Software integration
GAMP 5 compliant software that connects your solution to MES/EBR systems.
Analytics, measurement and QC solutions
Combining expertise in sensing, molecular and cell biology, microfluidics, electronics, optics and AI.
Automation and instrumentation development
Flexible, highly-skilled and bespoke multi-disciplinary teams developing your solution, including biology to hardware integration, biology development and optimisation.
Prototyping and early stage manufacture
Manufacture of up to 100s of instruments and 1000s of cartridges.
Regulated development
Design of 13485 or GAMP 5 compliant systems, suitable for GMP manufacture.
Usability
Human factors assessment, design for usability, use error analysis.
Late stage troubleshooting
Rapid and scientific approach enables an informed, risk-based response.
Our approach and capabilities
We deliver across the entire life of a project, from opportunity discovery to production engineering. Discover how our interdisciplinary teams of experts collaborate to tackle the toughest product development challenges.
Our campus and facilities
Our award-winning campus has been designed with a clear vision. To create a space which can support our people and our clients as we develop and deliver the very best technology solutions.
Software capability at TTP
Engaged in all stages of software and product development, our software capability at TTP covers the full spectrum—from in-depth analysis and system architecture to prototype design, implementation, and test development.
Manufacturing capability at TTP
Working seamlessly with our development teams, we take clients' products through prototype builds, clinical trials, pilot manufacture and more. Using TTP Manufacturing reduces uncertainty, risk and time to market for our clients.
Meet some of the team
Stuart Lowe
Wayne Bowen
Andrew Stratton
